Two treatment pathways exist for patients presenting with symptoms consistent with CVA that meet strict timing criteria and lack contraindications: thrombolysis or endovascular reperfusion therapy. Studies show that an estimated 4% of patients who receive thrombolytics for a presentation of acute neurological symptoms later receive a diagnosis of a stroke mimic.